Count rate measurement device and associated fission chamber calibration device
    1.
    发明授权
    Count rate measurement device and associated fission chamber calibration device 有权
    计数速率测量装置及相关的裂变室校准装置

    公开(公告)号:US09188684B2

    公开(公告)日:2015-11-17

    申请号:US12809574

    申请日:2008-12-22

    IPC分类号: G01T3/00 G01T1/185 G21C17/108

    CPC分类号: G01T3/00 G01T1/185

    摘要: A fission chamber count rate measurement device and to the associated fission chamber calibration device; the count rate measurement device comprises: (1) a measurement cell, which contains the fission chamber (CH); (2) a neutron generator, which emits neutrons in the form of periodic pulses towards the fission chamber; (3) a neutron counter (K), which detects and counts the neutrons emitted by the neutron generator; and (4) a computing circuit, which delivers, over a predetermined time interval, a fission chamber count rate normalized with reference to the number of neutrons counted by the neutron counter (K).

    摘要翻译: 裂变室计数率测量装置和相关的裂变室校准装置; 计数率测量装置包括:(1)包含裂变室(CH)的测量单元; (2)中子发生器,其以朝向裂变室的周期性脉冲的形式发射中子; (3)中子计数器(K),用于检测和计数由中子发生器发射的中子; 和(4)计算电路,其以预定的时间间隔递送参考由中子计数器(K)计数的中子数量归一化的裂变室计数速率。

    COUNT RATE MEASUREMENT DEVICE AND ASSOCIATED FISSION CHAMBER CALIBRATION DEVICE
    2.
    发明申请
    COUNT RATE MEASUREMENT DEVICE AND ASSOCIATED FISSION CHAMBER CALIBRATION DEVICE 有权
    计数速率测量装置和相关的振动台校准装置

    公开(公告)号:US20100266092A1

    公开(公告)日:2010-10-21

    申请号:US12809574

    申请日:2008-12-22

    IPC分类号: G21C17/108 G01T3/00

    CPC分类号: G01T3/00 G01T1/185

    摘要: A fission chamber count rate measurement device and to the associated fission chamber calibration device; the count rate measurement device comprises: (1) a measurement cell, which contains the fission chamber (CH); (2) a neutron generator, which emits neutrons in the form of periodic pulses towards the fission chamber; (3) a neutron counter (K), which detects and counts the neutrons emitted by the neutron generator; and (4) a computing circuit, which delivers, over a predetermined time interval, a fission chamber count rate normalized with reference to the number of neutrons counted by the neutron counter (K).

    摘要翻译: 裂变室计数率测量装置和相关的裂变室校准装置; 计数率测量装置包括:(1)包含裂变室(CH)的测量单元; (2)中子发生器,其以朝向裂变室的周期性脉冲的形式发射中子; (3)中子计数器(K),用于检测和计数由中子发生器发射的中子; 和(4)计算电路,其以预定的时间间隔递送参考由中子计数器(K)计数的中子数量归一化的裂变室计数速率。

    Device for measuring physical quantities of nuclear materials and method of employing such a device
    3.
    发明授权
    Device for measuring physical quantities of nuclear materials and method of employing such a device 有权
    用于测量核材料物理量的装置以及采用这种装置的方法

    公开(公告)号:US08759768B2

    公开(公告)日:2014-06-24

    申请号:US13002600

    申请日:2009-07-10

    IPC分类号: G01T1/167 G21F5/00

    摘要: A movable device for measuring physical quantities of nuclear materials contained in a shielded cell, which device can be brought up against the shielded cell and can be retracted therefrom, the device configured to carry out the measurement in the position in which it is against the shielded cell. The device includes a carriage, a support member placed on the carriage, and a shielded container placed on the support member. The shielded container includes a transfer container configured to store the nuclear material to be measured, and an opening configured to be aligned with an opening in one wall of the shielded cell. The support member is made of graphite and includes a housing accommodating a neutron emission module, a casing covering the shielded container, the casing being made of graphite, and a neutron measurement mechanism fastened to the casing.

    摘要翻译: 一种用于测量包含在屏蔽电池中的核材料的物理量的可移动装置,该装置可以抵靠屏蔽电池而被提起并且可以从屏蔽单元收回,该装置被配置为在与屏蔽电池相反的位置执行测量 细胞。 该装置包括滑架,放置在滑架上的支撑构件和放置在支撑构件上的屏蔽容器。 屏蔽容器包括被配置为存储要测量的核材料的转移容器和被构造为与屏蔽单元的一个壁中的开口对准的开口。 支撑构件由石墨制成,并且包括容纳中子发射模块的壳体,覆盖屏蔽容器的壳体,由石墨制成的壳体,以及紧固到壳体的中子测量机构。

    DEVICE FOR MEASURING PHYSICAL QUANTITIES OF NUCLEAR MATERIALS AND METHOD OF EMPLOYING SUCH A DEVICE
    4.
    发明申请
    DEVICE FOR MEASURING PHYSICAL QUANTITIES OF NUCLEAR MATERIALS AND METHOD OF EMPLOYING SUCH A DEVICE 有权
    用于测量核材料的物理量的装置和使用这种装置的方法

    公开(公告)号:US20110155920A1

    公开(公告)日:2011-06-30

    申请号:US13002600

    申请日:2009-07-10

    IPC分类号: G01T1/167 G01T1/00 B23P11/00

    摘要: A movable device for measuring physical quantities of nuclear materials contained in a shielded cell, which device can be brought up against the shielded cell and can be retracted therefrom, the device configured to carry out the measurement in the position in which it is against the shielded cell. The device includes a carriage, a support member placed on the carriage, and a shielded container placed on the support member. The shielded container includes a transfer container configured to store the nuclear material to be measured, and an opening configured to be aligned with an opening in one wall of the shielded cell. The support member is made of graphite and includes a housing accommodating a neutron emission module, a casing covering the shielded container, the casing being made of graphite, and a neutron measurement mechanism fastened to the casing.

    摘要翻译: 一种用于测量包含在屏蔽电池中的核材料的物理量的可移动装置,该装置可以抵靠屏蔽电池而被提起并且可以从屏蔽单元收回,该装置被配置为在与屏蔽电池相反的位置执行测量 细胞。 该装置包括滑架,放置在滑架上的支撑构件和放置在支撑构件上的屏蔽容器。 屏蔽容器包括被配置为存储要测量的核材料的转移容器和被构造为与屏蔽单元的一个壁中的开口对准的开口。 支撑构件由石墨制成,并且包括容纳中子发射模块的壳体,覆盖屏蔽容器的壳体,由石墨制成的壳体,以及紧固到壳体的中子测量机构。

    PEPTIDE-BASED COMPOUNDS AS NEW INHIBITORS OF METALLOECTOPEPTIDASES, COMPOSITIONS COMPRISING SAID COMPOUNDS AND THEIR PHARMACEUTICAL AND COSMETIC USES

    公开(公告)号:US20100062052A1

    公开(公告)日:2010-03-11

    申请号:US12524955

    申请日:2008-02-04

    申请人: Philippe Bernard

    发明人: Philippe Bernard

    摘要: The invention relates to a compound that inhibits a metallo-ectopeptidase, selected in the group consisting of x-aa2-aa1-z, x-aa3-aa2-aa1-z, x-aa4-aa3-aa2-aa1-z and x-aa5-aa4-aa3-aa2-aa1-z, wherein: aa1 and aa4, independently from each other, represent an arginine amino acid, an histidine amino acid, an asparagine amino acid or a lysine amino acid, aa2 represents a serine amino acid, a glycine amino acid, a threonine amino acid or an alanine amino acid, aa3 represents a phenylalanine amino acid, a leucine amino acid, an isoleucine amino acid, a tyrosine amino acid or a tryptophan amino acid, aa5 represents a glutamine amino acid, a glutamic acid amino acid, an asparagines amino-acid or a lysine amino acid, x and z, independently from each other, represent: —H; —OH1 SH; —a halogen atom, —an amino group, —an alkyl, haloalkyl or heteroalkyl group containing from 1 to 30 carbon atoms, linear or branched, —an alkenyl or alkynyl group containing from 2 to 30 carbon atoms, linear or branched, —a cycloalkyl, cycloakenyl, cycloalkynyl or an heterocyclic group containing from 3 to 30 carbon atoms, linear or branched, —one or more aryl or heteroaryl groups containing from 3 to 10 carbon atoms per cycle, —a alkoxy, thioalkyl, sulfonylalkyl, aminoalkyl containing from 1 to 30 carbon atoms, linear or branched, —one or more heterocyclic group, containing from 5 to 10 carbon atoms per cycle, said groups being optionally substituted by one or more halogen atoms, alkyl groups, hydroxy groups, alkoxy groups, aryloxy groups, acyloxy groups, carbamoyloxy groups, carboxy groups, mercapto groups, alkylthio groups, acylthio groups, arylthio groups, aryl groups, heterocyclic groups, heteroaryl groups or amino groups.

    Cloning and/or sequencing vector
    6.
    发明授权
    Cloning and/or sequencing vector 失效
    克隆和/或测序载体

    公开(公告)号:US5910438A

    公开(公告)日:1999-06-08

    申请号:US379614

    申请日:1995-07-20

    CPC分类号: C12N15/70

    摘要: A cloning and/or sequencing vector (1) comprises a nucleotide promoter sequence (3) and a nucleotide sequence (4) coding for a fusion protein active as a poison, which nucleotide sequence (4) is obtained by fusion of a coding nucleotide sequence (5) containing several unique cloning sites with a nucleotide sequence (6) coding for a poison protein, wherein the nucleotide sequences (3) and (4) are incorporated in an autonomous replication vector (2).

    摘要翻译: PCT No.PCT / BE93 / 00051 Sec。 371日期1995年7月20日 102(e)日期1995年7月20日PCT 1993年8月2日PCT公布。 第WO94 / 03616号公报 日期1994年2月17日克隆和/或测序载体(1)包含核苷酸启动子序列(3)和编码作为毒物活化的融合蛋白的核苷酸序列(4),该核苷酸序列(4)通过融合获得 的编码核苷酸序列(5),其含有编码毒蛋白的核苷酸序列(6)的几个独特的克隆位点,其中所述核苷酸序列(3)和(4)并入自主复制载体(2)中。

    Hydrogen reduction of carbonaceous source to form carbon monoxide
    7.
    发明授权
    Hydrogen reduction of carbonaceous source to form carbon monoxide 失效
    碳源的氢还原形成一氧化碳

    公开(公告)号:US4758249A

    公开(公告)日:1988-07-19

    申请号:US4246

    申请日:1987-01-05

    摘要: Carbon dioxide is facilely converted into carbon monoxide and water, and advantageously into a syngas, by establishing a thermally homogeneous gaseous admixture including carbon dioxide and hydrogen having a temperature of at least 800.degree. C., within a period of time essentially insufficient for the production of carbon monoxide therefrom, and wherein said carbon dioxide is next autogenously reduced under reaction equilibrium conditions to carbon monoxide and water by reaction with hydrogen, with each molecule of carbon monoxide formed having, or essentially instantaneously being brought to, a temperature of at least 800.degree. C.

    摘要翻译: 通过在基本上不足以用于生产的时间内建立包含二氧化碳和至少800℃温度的氢的热均匀气体混合物,将二氧化碳容易地转化为一氧化碳和水,并有利地转化为合成气 的一氧化碳,并且其中所述二氧化碳接着在与氢气反应的反应平衡条件下自发还原成一氧化碳和水,每分子形成的一氧化碳分别具有或基本上瞬间地达到至少800 DEG C.

    DEVICE FOR MEASURING COMPLIANCE WITH OXYGEN THERAPY USING A THREE-DIMENSIONAL ACCELEROMETER
    8.
    发明申请
    DEVICE FOR MEASURING COMPLIANCE WITH OXYGEN THERAPY USING A THREE-DIMENSIONAL ACCELEROMETER 审中-公开
    使用三维加速度计测量符合氧气治疗的装置

    公开(公告)号:US20130310713A1

    公开(公告)日:2013-11-21

    申请号:US13983217

    申请日:2012-01-11

    IPC分类号: A61B5/00 A61B5/11 A61M16/00

    摘要: The invention relates to a device for measuring patient compliance with oxygen therapy, including a casing (4) comprising means for detection of the oxygen therapy in order to evaluate data relating to the treatment; and means for measuring a state of physical activity of the patient. Preferably, the means for measuring a state of physical activity of the patient comprise at least one sensor which senses movement of the patient's body and outputs data relating to the spatial displacement of the patient's body, for example a three-dimensional accelerometer (28); and processing means (40, 42) for processing the body displacement data in order to supply a state of physical activity of the patient chosen from a sleeping state, a resting state and an active state.

    摘要翻译: 本发明涉及一种用于测量患者对氧疗的依从性的装置,包括壳体(4),其包括用于检测氧疗的装置,以便评估与治疗有关的数据; 以及用于测量患者的身体活动状态的装置。 优选地,用于测量患者的身体活动状态的装置包括至少一个感测患者身体运动的传感器,并且输出与患者身体例如三维加速度计(28)的空间位移有关的数据。 以及用于处理身体位移数据以便提供从休眠状态,静止状态和活动状态中选择的患者的身体活动状态的处理装置(40,42)。

    Use of silymarin and/or constituents thereof as skin or hair pigmentation promoters
    9.
    发明授权
    Use of silymarin and/or constituents thereof as skin or hair pigmentation promoters 有权
    使用水飞蓟素和/或其成分作为皮肤或毛发色素启动子

    公开(公告)号:US08569358B2

    公开(公告)日:2013-10-29

    申请号:US11818943

    申请日:2006-02-13

    IPC分类号: A01K43/32 A61K31/335

    摘要: Describe is a method of administering to a subject silymarin, or of the main constituents thereof alone or as a mixture, chosen from silybin (or 2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3, 5,7-trihydroxy-4-oxobenzopyran-2-yl)benzodioxine), isosilybin, silydianin, silychristin, silandrin, silymonin and taxifolin, isolated enantiomers thereof and also salts thereof.

    摘要翻译: 描述是向受试者水飞蓟素或其主要成分单独或作为混合物施用水飞蓟宾(或2,3-二氢-3-(4-羟基-3-甲氧基苯基)-2-(羟甲基 )-6-(3,5,7-三羟基-4-氧代苯并吡喃-2-基)苯并二氧杂环己烯),异水松杉碱,硅藻土,水滑石,丝兰蛋白,silymonin和taxifolin,其分离的对映体及其盐。

    PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOL DEPENDENCY
    10.
    发明申请
    PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOL DEPENDENCY 审中-公开
    用于治疗酒精依赖性的药物组合物

    公开(公告)号:US20120289514A1

    公开(公告)日:2012-11-15

    申请号:US13519042

    申请日:2010-12-29

    摘要: Pharmaceutical composition for treating alcohol dependence in humans comprising two active ingredients: a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine; and a compound having an antagonistic action on the alpha1-noradrenergic receptors selected from prazosin, alfuzosin, terazosin and tamsulosin.

    摘要翻译: 用于治疗人类酒精依赖性的药物组合物,其包含两种活性成分:对选择为赛庚啶的5-HT2血清素能受体具有拮抗作用的化合物; 以及对选自哌唑嗪,阿夫唑嗪,特拉唑嗪和坦索罗辛的α1-去甲肾上腺素能受体具有拮抗作用的化合物。